References
- Helminiak L, Mishra S, Kim HK. Pathogenicity and virulence of rickettsia. Virulence. 2022;13(1):1752–1771. doi:10.1080/21505594.2022.2132047
- Mahara F, Koga K, Sawada S, et al. わ が国初 の紅斑 熱 リケ ッチ ア感 染 症[The first report of the rickettsial infections of spotted fever group in Japan: three clinical cases]. Kansenshogaku Zasshi. 1985;59(11):1165–1171. Japanese. doi:10.11150/kansenshogakuzasshi1970.59.1165
- Li H, Zhang PH, Du J, et al. Rickettsia japonica infections in Humans, Xinyang, China, 2014–2017. Emerg Infect Dis. 2019;25(9):1719–1722. doi:10.3201/eid2509.171421
- Nakata R, Motomura M, Tokuda M, et al. A case of Japanese spotted fever complicated with central nervous system involvement and multiple organ failure. Intern Med. 2012;51(7):783–786. doi:10.2169/internalmedicine.51.6214
- Gao S, Li L, Zhou X, et al. Fatal rickettsia japonica infection complicating disseminated intravascular coagulation in Yichang, China. Infect Drug Resist. 2022;15:6613–6623. doi:10.2147/IDR.S383917
- Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019;14:319–338. doi:10.1146/annurev-pathmechdis-012418-012751
- Lu Q, Yu J, Yu L, et al. Rickettsia japonica Infections in Humans, Zhejiang Province, China, 2015. Emerg Infect Dis. 2018;24(11):2077–2079. doi:10.3201/eid2411.170044
- Seki M, Ikari N, Yamamoto S, et al. Severe Japanese spotted fever successfully treated with fluoroquinolone. Intern Med. 2006;45(22):1323–1326. doi:10.2169/internalmedicine.45.1831
- Noguchi M, Oshita S, Yamazoe N, Miyazaki M, Takemura YC. Important clinical features of Japanese Spotted Fever. Am J Trop Med Hyg. 2018;99(2):466–469. doi:10.4269/ajtmh.17-0576
- Araki M, Takatsuka K, Kawamura J, Kanno Y. Japanese spotted fever involving the central nervous system: two case reports and a literature review. J Clin Microbiol. 2002;40(10):3874–3876. doi:10.1128/JCM.40.10.3874-3876.2002
- Wada T, Mori H, Kida K, Shindo K. Japanese spotted fever with post-infectious encephalitis. IDCases. 2023;31:e01658. doi:10.1016/j.idcr.2022.e01658
- Huemer M, Mairpady SS, Brugger SD, Zinkernagel AS. Antibiotic resistance and persistence-Implications for human health and treatment perspectives. EMBO Rep. 2020;21(12):e51034. doi:10.15252/embr.202051034
- Tai K, Iwasaki H, Ikegaya S, et al. Significantly higher cytokine and chemokine levels in patients with Japanese spotted fever than in those with Tsutsugamushi disease. J Clin Microbiol. 2014;52(6):1938–1946. doi:10.1128/JCM.03238-13